메뉴 건너뛰기




Volumn 101, Issue 11, 2004, Pages 2557-2566

Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma

Author keywords

Gene therapy; Immunotherapy; Interleukin 2; Leuvectin; Renal cell carcinoma

Indexed keywords

1,2 DIMYRISTYLOXYPROPYL 3 DIMETHYLHYDROXYETHYL AMMONIUM BROMIDE; ANTINEOPLASTIC AGENT; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; INTERLEUKIN 2; LEUVECTIN; LIPID; PLASMID DNA; UNCLASSIFIED DRUG;

EID: 8844237512     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20653     Document Type: Article
Times cited : (24)

References (32)
  • 2
    • 0030695173 scopus 로고    scopus 로고
    • Renal cell carcinoma: Recent progress and future directions
    • Mulders P, Figlin R, deKernion JB, et al. Renal cell carcinoma: recent progress and future directions. Cancer Res. 1997;57:5189-5195.
    • (1997) Cancer Res , vol.57 , pp. 5189-5195
    • Mulders, P.1    Figlin, R.2    DeKernion, J.B.3
  • 3
    • 0029982152 scopus 로고    scopus 로고
    • Renal cell carcinoma
    • Savage PD. Renal cell carcinoma. Curr Opin Oncol. 1996;8:247-251.
    • (1996) Curr Opin Oncol , vol.8 , pp. 247-251
    • Savage, P.D.1
  • 4
    • 0035163459 scopus 로고    scopus 로고
    • Recent advances in kidney cancer and metastatic disease
    • Kirkali Z, Tuzel E, Mungan MU. Recent advances in kidney cancer and metastatic disease. BJU Int. 2001;68:818-824.
    • (2001) BJU Int , vol.68 , pp. 818-824
    • Kirkali, Z.1    Tuzel, E.2    Mungan, M.U.3
  • 5
    • 0028929682 scopus 로고
    • Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy
    • Fyfe G, Fisher RI, Rosenberg SA, Sznol A, Parkinson DR, Louie AC. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J Clin Oncol. 1995;13:688-696.
    • (1995) J Clin Oncol , vol.13 , pp. 688-696
    • Fyfe, G.1    Fisher, R.I.2    Rosenberg, S.A.3    Sznol, A.4    Parkinson, D.R.5    Louie, A.C.6
  • 6
    • 0027944183 scopus 로고
    • Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma
    • Guleria AS, Yang JC, Topalian SL, et al. Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma. J Clin Oncol. 1994;12:2714-2722.
    • (1994) J Clin Oncol , vol.12 , pp. 2714-2722
    • Guleria, A.S.1    Yang, J.C.2    Topalian, S.L.3
  • 7
    • 0031812910 scopus 로고    scopus 로고
    • Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic disease
    • Kammula US, White DE, Rosenberg SA. Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic disease. Cancer. 1998;83:797-805.
    • (1998) Cancer , vol.83 , pp. 797-805
    • Kammula, U.S.1    White, D.E.2    Rosenberg, S.A.3
  • 8
    • 0027739283 scopus 로고
    • Interleukin-2 antitumor and effector cell responses
    • Hawkins MJ. Interleukin-2 antitumor and effector cell responses. Semin Oncol. 1993;20:52-59.
    • (1993) Semin Oncol , vol.20 , pp. 52-59
    • Hawkins, M.J.1
  • 9
    • 0029947360 scopus 로고    scopus 로고
    • IL-2 gene therapy of solid tumors: An approach for the prevention of signal transduction defects in T cells
    • Zier KS, Gansbacher B. IL-2 gene therapy of solid tumors: an approach for the prevention of signal transduction defects in T cells. J Mol Med. 1996;74:127-134.
    • (1996) J Mol Med , vol.74 , pp. 127-134
    • Zier, K.S.1    Gansbacher, B.2
  • 10
    • 17144451211 scopus 로고    scopus 로고
    • Plasmid DNA gene therapy: Studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo
    • Parker SE, Khatibi S, Margalith M, et al. Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo. Cancer Gene Ther. 1996;3:175-185.
    • (1996) Cancer Gene Ther , vol.3 , pp. 175-185
    • Parker, S.E.1    Khatibi, S.2    Margalith, M.3
  • 13
    • 0032886544 scopus 로고    scopus 로고
    • Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: Phase I/II experience
    • Galanis E, Hersh EM, Stopeck AT, et al. Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: Phase I/II experience. J Clin Oncol. 1999;17:3313-3323.
    • (1999) J Clin Oncol , vol.17 , pp. 3313-3323
    • Galanis, E.1    Hersh, E.M.2    Stopeck, A.T.3
  • 14
    • 0023013967 scopus 로고
    • Immunophenotypic profiles in well-differentiated lymphoproliferative disorders, with emphasis on small lymphocytic lymphoma
    • Spier CM, Crogan TM, Fielder K, et al. Immunophenotypic profiles in well-differentiated lymphoproliferative disorders, with emphasis on small lymphocytic lymphoma. Hum Pathol. 1986;17:1126-1136.
    • (1986) Hum Pathol , vol.17 , pp. 1126-1136
    • Spier, C.M.1    Crogan, T.M.2    Fielder, K.3
  • 15
    • 0035900808 scopus 로고    scopus 로고
    • Cancer gene therapy clinical trials: Lessons for the future
    • Galanis E, Russell S. Cancer gene therapy clinical trials: lessons for the future. Br J Cancer. 2001;85:1432-1436.
    • (2001) Br J Cancer , vol.85 , pp. 1432-1436
    • Galanis, E.1    Russell, S.2
  • 16
    • 0028978028 scopus 로고
    • Cancer gene therapy using plasmid DNA: Purification of DNA for human clinical trials
    • Horn NA, Meek JA, Budahazi G, et al. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials. Hum Gene Ther. 1995;6:565-573.
    • (1995) Hum Gene Ther , vol.6 , pp. 565-573
    • Horn, N.A.1    Meek, J.A.2    Budahazi, G.3
  • 17
    • 0026813323 scopus 로고
    • Karnofsky Memorial Lecture: The immunotherapy and gene therapy of cancer
    • Rosenberg SA. Karnofsky Memorial Lecture: the immunotherapy and gene therapy of cancer. J Clin Oncol. 1992;10:180-199.
    • (1992) J Clin Oncol , vol.10 , pp. 180-199
    • Rosenberg, S.A.1
  • 18
    • 0030944023 scopus 로고    scopus 로고
    • Bioactivity of autologous irradiated renal cell carcinoma colony-stimulating factor gene transfer
    • Simons JW, Jaffee EM, Weber CE, et al. Bioactivity of autologous irradiated renal cell carcinoma colony-stimulating factor gene transfer. Cancer Res. 1997;57:1537-1546.
    • (1997) Cancer Res , vol.57 , pp. 1537-1546
    • Simons, J.W.1    Jaffee, E.M.2    Weber, C.E.3
  • 20
    • 0033765794 scopus 로고    scopus 로고
    • Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies
    • Nelson WG, Simons JW, Mikhak BV, et al. Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies. Cancer Chemother Pharmacol. 2000;46:S67-S72.
    • (2000) Cancer Chemother Pharmacol , vol.46
    • Nelson, W.G.1    Simons, J.W.2    Mikhak, B.V.3
  • 21
    • 0031649098 scopus 로고    scopus 로고
    • Ex vivo gene therapy using cytokine-transduced tumor vaccines: Molecular and clinical pharmacology
    • Simons JW, Mikhak B. Ex vivo gene therapy using cytokine-transduced tumor vaccines: molecular and clinical pharmacology. Semin Oncol. 1998;24:661-676.
    • (1998) Semin Oncol , vol.24 , pp. 661-676
    • Simons, J.W.1    Mikhak, B.2
  • 22
    • 0030449996 scopus 로고    scopus 로고
    • Immunotherapy of metastatic renal cell cancer
    • Goey SH, Verweij J, Stoter G. Immunotherapy of metastatic renal cell cancer. Ann Oncol. 1996;7:887-900.
    • (1996) Ann Oncol , vol.7 , pp. 887-900
    • Goey, S.H.1    Verweij, J.2    Stoter, G.3
  • 23
    • 7144227930 scopus 로고    scopus 로고
    • Recombinant human interleukin-2, recombinant human interferon-alfa-2a, or both in metastatic renal cell carcinoma
    • Negrier S, Escudier B, Lasset C, et al. Recombinant human interleukin-2, recombinant human interferon-alfa-2a, or both in metastatic renal cell carcinoma. N Engl J Med. 1998;338:1272-1278.
    • (1998) N Engl J Med , vol.338 , pp. 1272-1278
    • Negrier, S.1    Escudier, B.2    Lasset, C.3
  • 24
    • 0033514050 scopus 로고    scopus 로고
    • Interferon-α and survival in metastatic renal carcinoma: Early results of a randomised controlled trial
    • Medical Research Council Renal Cancer Collaborators. Interferon-α and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Lancet. 1999;353:14-17.
    • (1999) Lancet , vol.353 , pp. 14-17
  • 25
    • 0032580508 scopus 로고    scopus 로고
    • Metastatic renal cell carcinoma: What causes occasional dramatic regressions?
    • Young RC. Metastatic renal cell carcinoma: what causes occasional dramatic regressions? N Engl J Med. 1998;338:1305-1306.
    • (1998) N Engl J Med , vol.338 , pp. 1305-1306
    • Young, R.C.1
  • 26
    • 0031887379 scopus 로고    scopus 로고
    • Are cytokine responses in renal cell cancer the product of placebo effect of treatment or true biotherapy? What trials are needed now?
    • Oliver RT. Are cytokine responses in renal cell cancer the product of placebo effect of treatment or true biotherapy? What trials are needed now? Br J Cancer. 1998;77:1318-1320.
    • (1998) Br J Cancer , vol.77 , pp. 1318-1320
    • Oliver, R.T.1
  • 27
    • 0033919797 scopus 로고    scopus 로고
    • Local cytokine therapy of cancer: Interleukin-2, interferons and related cytokines
    • Bubenik I, Den Otter W, Huland E. Local cytokine therapy of cancer: interleukin-2, interferons and related cytokines. Cancer Immunol Immunother. 2000;49:116-122.
    • (2000) Cancer Immunol Immunother , vol.49 , pp. 116-122
    • Bubenik, I.1    Den Otter, W.2    Huland, E.3
  • 28
    • 0034660885 scopus 로고    scopus 로고
    • In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: Induction of tumor regression and potent antitumor immunity
    • Egilmez NK, Jong YS, Sabel MS, Jacob JS, Mathiowitz E, Bankert RB. In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity. Cancer Res. 2000;60:3832-3837.
    • (2000) Cancer Res , vol.60 , pp. 3832-3837
    • Egilmez, N.K.1    Jong, Y.S.2    Sabel, M.S.3    Jacob, J.S.4    Mathiowitz, E.5    Bankert, R.B.6
  • 29
    • 0036009005 scopus 로고    scopus 로고
    • Prognostic and predictive factors of immunotherapy in metastatic renal cell carcinoma
    • van Herpen CM, De Mulder PH. Prognostic and predictive factors of immunotherapy in metastatic renal cell carcinoma. Crit Rev Oncol Hematol. 2002;41:327-334.
    • (2002) Crit Rev Oncol Hematol , vol.41 , pp. 327-334
    • Van Herpen, C.M.1    De Mulder, P.H.2
  • 30
    • 0034860187 scopus 로고    scopus 로고
    • A literature analysis of prognostic factors for response and quality of response of patients with renal cell carcinoma to interleukin-2-based therapy
    • Elias L, Hunt WC. A literature analysis of prognostic factors for response and quality of response of patients with renal cell carcinoma to interleukin-2-based therapy. Oncology. 2001;61:91-101.
    • (2001) Oncology , vol.61 , pp. 91-101
    • Elias, L.1    Hunt, W.C.2
  • 31
    • 0032772880 scopus 로고    scopus 로고
    • Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma
    • Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol. 1999;17:2530-2540.
    • (1999) J Clin Oncol , vol.17 , pp. 2530-2540
    • Motzer, R.J.1    Mazumdar, M.2    Bacik, J.3    Berg, W.4    Amsterdam, A.5    Ferrara, J.6
  • 32
    • 0035816315 scopus 로고    scopus 로고
    • High density oligonucleotide array analysis of interferon-α2a sensitivity and transcriptional response in melanoma cells
    • Certa U, Seiler M, Padovan E, Spagnoli GC. High density oligonucleotide array analysis of interferon-α2a sensitivity and transcriptional response in melanoma cells. Br J Cancer. 2001;85:107-114.
    • (2001) Br J Cancer , vol.85 , pp. 107-114
    • Certa, U.1    Seiler, M.2    Padovan, E.3    Spagnoli, G.C.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.